Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemnovatic is a specialized chemical company and contract development and manufacturing organization (CDMO) focused on high-purity nicotine and cannabinoid products. The company provides pharmaceutical-grade raw materials, including nicotine salts and CBD isolates, to the vaping, pharmaceutical, and cosmetic industries. Beyond raw material supply, Chemnovatic offers comprehensive services such as product formulation, laboratory testing, and private label manufacturing. Their operations are supported by advanced R&D facilities and adherence to international quality standards like ISO 9001 and HACCP. The company is a key player in the European nicotine market, known for its NicPure brand and regulatory compliance expertise. They also provide specialized chemical processing services, including molecular distillation and custom synthesis for third-party clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemnovatic.